{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:14:08Z","timestamp":1793916848031,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-024-01118-3","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:18:14Z","timestamp":1732061894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of different populations accessing online overdose response training and harm reduction supplies (ADORES)"],"prefix":"10.1186","volume":"21","author":[{"given":"Michaela","family":"Pacheco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiodun","family":"Ologunowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"1118_CR1","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics System, Mortality 2018\u20132022 on CDC WONDER Online Database, released in 2024. Data are from the Multiple Cause of Death Files, 2018\u20132022, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. http:\/\/wonder.cdc.gov\/ucd-icd10-expanded.html. Accessed on 2024 May 6."},{"key":"1118_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and Geographic patterns in drug and synthetic opioid overdose deaths \u2014 United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep. 2021;70:202\u20137. https:\/\/doi.org\/10.15585\/mmwr.mm7006a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1118_CR3","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:112340","author":"H Hedegaard","year":"2021","unstructured":"Hedegaard H, Mini\u00f1o AM, Spencer MR, Warner M. Drug overdose deaths in the United States, 1999\u20132020. Hyattsville, MD: National Center for Health Statistics; 2021. https:\/\/doi.org\/10.15620\/cdc:112340. NCHS Data Brief, no 428."},{"key":"1118_CR4","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:135849","author":"MR Spencer","year":"2024","unstructured":"Spencer MR, Garnett MF, Mini\u00f1o AM. Drug overdose deaths in the United States, 2002\u20132022. Hyattsville, MD: National Center for Health Statistics; 2024. https:\/\/doi.org\/10.15620\/cdc:135849. NCHS Data Brief, no 491."},{"key":"1118_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227966","author":"SF Altekrause","year":"2020","unstructured":"Altekrause SF, Cosgrove CM, Altekrause WC, Jenkins RA, Blanco C. Socioeconomic risk factors for fatal overdoses in the United States: mortality disparities in American communities study (MDAC). PLoS ONE. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0227966.","journal-title":"PLoS ONE"},{"key":"1118_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2023.100102","author":"JB Britz","year":"2023","unstructured":"Britz JB, O\u2019Loughlin KM, Henry TL, Richards A, Sabo RT, Saunders HG, et al. Rising racial disparities in opioid mortality and undertreatment of opioid use disorder and mental health comorbidities in Virginia. AJPM Focus. 2023. https:\/\/doi.org\/10.1016\/j.focus.2023.100102.","journal-title":"AJPM Focus"},{"key":"1118_CR7","unstructured":"Naloxone. In: Clinical Pharmacology [database on the Internet]. Tampa (FL): Elsevier; 2017 [cited 2024 Jun 26]. Available from: http:\/\/www.clinicalpharmacology.com. Subscription required to view."},{"key":"1118_CR8","unstructured":"Naloxone [package insert]. Richmond, VA: Kaleo, Inc; 2022."},{"key":"1118_CR9","unstructured":"Food and Drug Administration. FDA approves new hand-held auto-injector to reverse opioid overdose. 2014. http:\/\/wayback.archive-it.org\/7993\/20161022205011\/http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm391465.htm. Accessed 2024 Jun 25."},{"key":"1118_CR10","unstructured":"Food and Drug Administration. FDA moves quickly to approve easy-to-use nasal spray to treat opioid overdose. 2015. https:\/\/wayback.archive-it.org\/7993\/20180125101447\/https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm473505.htm. Accessed 2024 Jun 25."},{"key":"1118_CR11","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2020.305620","author":"TC Green","year":"2020","unstructured":"Green TC, Davis C, Xuan Z, Walley AY, Bratberg J. Laws mandating coprescription of naloxone and their impact on naloxone prescription in five US states, 2014\u20132018. Am J Public Health. 2020. https:\/\/doi.org\/10.2105\/AJPH.2020.305620.","journal-title":"Am J Public Health"},{"key":"1118_CR12","unstructured":"Davis C, Lieberman AJ, Larkin K. Naloxone prescription mandates. The Network for Public Health Law. 2023. https:\/\/www.networkforphl.org\/wp-content\/uploads\/2023\/07\/Fact-Sheet-Naloxone-Prescription-Mandates-2022-update.pdf"},{"key":"1118_CR13","unstructured":"Drug overdose death rates. NIDA. 2024. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates. Accessed 2024 Jun 27."},{"issue":"8","key":"1118_CR14","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.2105\/AJPH.2020.305696","volume":"110","author":"AJ Holmgren","year":"2020","unstructured":"Holmgren AJ, Botelho A, Brandt AM. A history of Prescription Drug Monitoring Programs in the United States: political appeal and Public Health Efficacy. Am J Public Health. 2020;110(8):1191\u20137. https:\/\/doi.org\/10.2105\/AJPH.2020.305696. Epub 2020 Jun 18. PMID: 32552023; PMCID: PMC7349461.","journal-title":"Am J Public Health"},{"issue":"5","key":"1118_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jama.2019.7988","volume":"322","author":"CM Jones","year":"2019","unstructured":"Jones CM, Compton W, Vythilingam M, Giroir B. Naloxone co-prescribing to patients receiving prescription opioids in the Medicare Part D Program, United States, 2016\u20132017. JAMA. 2019;322(5):462\u20134. https:\/\/doi.org\/10.1001\/jama.2019.7988. PMID: 31386124; PMCID: PMC6686765.","journal-title":"JAMA"},{"key":"1118_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.13861","author":"X Zang","year":"2024","unstructured":"Zang X, Skinner A, Krieger MS, Behrends CN, Park JN, Green TC, et al. Evaluation of strategies to enhance community-based naloxone distribution supported by an opioid settlement. JAMA Netw Open. 2024. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.13861.","journal-title":"JAMA Netw Open"},{"key":"1118_CR17","unstructured":"Food and Drug Administration. FDA approves first over-the-counter naloxone nasal spray. 2023. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-over-counter-naloxone-nasal-spray. Accessed 2024 Jun 25."},{"key":"1118_CR18","unstructured":"Food and Drug Administration. FDA approves second over-the-counter naloxone nasal spray product. 2023. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-second-over-counter-naloxone-nasal-spray-product. Accessed 2024 Jun 25."},{"key":"1118_CR19","unstructured":"Lifesaving naloxone. CDC. 2024. https:\/\/www.cdc.gov\/stop-overdose\/caring\/naloxone.html#cdc_generic_section_4-who-should-carry-naloxone. Accessed 2024 Jun 25."},{"key":"1118_CR20","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2021.306306","author":"A Razaghizad","year":"2021","unstructured":"Razaghizad A, Windle SB, Filion KB, Gore G, Kudrina I, Paraskevopoulous E, et al. The effect of overdose education and naloxone distribution: an umbrella review of systematic reviews. Am J Public Health. 2021. https:\/\/doi.org\/10.2105\/AJPH.2021.306306.","journal-title":"Am J Public Health"},{"key":"1118_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40352-023-00250-9","author":"CH Dahlem","year":"2023","unstructured":"Dahlem CH, Patil R, Khadr L, Ploutz-Snyder RH, Boyd C, Shuman CJ. Effectiveness of take ACTION online naloxone training for law enforcement officers. Health Justice. 2023. https:\/\/doi.org\/10.1186\/s40352-023-00250-9.","journal-title":"Health Justice"},{"key":"1118_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00696-4","author":"MV Galiher","year":"2022","unstructured":"Galiher MV, Huffman M. Attitude changes following short-form opioid overdose video education: a pilot study. Harm Reduct J. 2022. https:\/\/doi.org\/10.1186\/s12954-022-00696-4.","journal-title":"Harm Reduct J"},{"key":"1118_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-023-01321-6","author":"L Schwieger","year":"2024","unstructured":"Schwieger L, Carpenter JE, Moran TP, Erowid F, Cornelison M, Evans D, et al. Access to, experience with, and attitudes towards take home naloxone: an online survey. J Community Health. 2024. https:\/\/doi.org\/10.1007\/s10900-023-01321-6.","journal-title":"J Community Health"},{"key":"1118_CR24","doi-asserted-by":"publisher","unstructured":"Fairbarn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017. https:\/\/doi.org\/10.1016\/j.drugpo.2017.06.005.","DOI":"10.1016\/j.drugpo.2017.06.005"},{"key":"1118_CR25","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2020.306124","author":"C Yang","year":"2021","unstructured":"Yang C, Favaro J, Meacham MC. NEXT harm reduction: an online, mail-based naloxone distribution and harm-reduction program. Am J Public Health. 2021. https:\/\/doi.org\/10.2105\/AJPH.2020.306124.","journal-title":"Am J Public Health"},{"key":"1118_CR26","unstructured":"NEXT Distro.https:\/\/nextdistro.org (2024). Accessed 2024 Jun 24."},{"key":"1118_CR27","unstructured":"Rhode Island Department of Health. Overdose fatalities. RIDOH Drug Overdose Surveillance Data Hub. https:\/\/ridoh-drug-overdose-surveillance-fatalities-rihealth.hub.arcgis.com (2024). Accessed 2024 May 6."},{"key":"1118_CR28","unstructured":"Community First Responder Program. https:\/\/web.uri.edu\/cfrp\/ (2024). The University of Rhode Island. Accessed 2024 Apr 8."},{"key":"1118_CR29","unstructured":"Prevent Overdose RI. https:\/\/preventoverdoseri.org (2024). Rhode Island Department of Health. Accessed 2024 Apr 8."},{"key":"1118_CR30","unstructured":"URI Community First Responder Program ROTA-R. https:\/\/web.uri.edu\/rota-r\/ (2024). The University of Rhode Island. Accessed 2024 Apr 8."},{"key":"1118_CR31","unstructured":"Defining rural Rhode Island. Rhode Island Department of Health. 2022. https:\/\/health.ri.gov\/publications\/definitions\/2022Rural-definition.pdf. Accessed 2024 Apr 8."},{"key":"1118_CR32","unstructured":"Rhode Island city and town income from American Community 5-year estimates 2017\u20132021. Rhode Island Department of Labor and Training. 2022. https:\/\/dlt.ri.gov\/sites\/g\/files\/xkgbur571\/files\/documents\/pdf\/lmi\/towninc.pdf. Accessed 2024 Apr 8."},{"key":"1118_CR33","doi-asserted-by":"publisher","DOI":"10.2196\/13300","author":"AJ Greenberg-Worisek","year":"2019","unstructured":"Greenberg-Worisek AJ, Kurani S, Finney Ruten LJ, Blake KD, Hesse BW. Tracking healthy people 2020 internet, broadband, and mobile device access goals: an update using data from the health information national trends survey. J Med Internet Res. 2019. https:\/\/doi.org\/10.2196\/13300.","journal-title":"J Med Internet Res"},{"key":"1118_CR34","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.22-00343","author":"N Dang","year":"2023","unstructured":"Dang N, Khunte M, Zhong A, Chatterjee A. Naloxone online information exceeds the recommended reading level for patient education materials. JSAD. 2023. https:\/\/doi.org\/10.15288\/jsad.22-00343.","journal-title":"JSAD"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-024-01118-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T01:05:54Z","timestamp":1732064754000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-024-01118-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1186\/s12954-024-01118-3","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"},{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study uses previously captured, voluntarily-provided data and was approved by the University of Rhode Island Institutional Review Board (IRB reference #2124391-2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}